|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 316.80 CHF | -0.35% |
|
+2.16% | +23.99% |
| 07:30pm | US FDA approves Innoviva's oral antibiotic for gonorrhea | RE |
| 02:05pm | Natera and MEDSIR to Collaborate on the Mirador Trial in Breast Cancer | CI |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.35% | +2.16% | +9.73% | +18.03% | +23.99% | +23.80% | +4.01% | +3.65% | +18.79% | 342B | |
| +1.80% | +1.70% | +0.96% | +36.02% | +33.10% | +31.34% | +179.78% | +550.69% | +1,113.40% | 904B | |
| +0.75% | +4.78% | +8.84% | +18.83% | +46.30% | +44.68% | +18.97% | +41.93% | +107.13% | 506B | |
| -0.29% | -1.22% | -4.25% | +2.28% | +25.67% | +28.95% | +35.08% | +114.32% | +302.81% | 396B | |
| -1.12% | -0.52% | -0.16% | +12.45% | +28.43% | +27.58% | +18.41% | +64.75% | +210.48% | 283B | |
| -0.45% | -1.29% | +1.36% | +3.65% | +18.94% | +19.97% | +23.42% | +29.35% | +26.27% | 256B | |
| +1.30% | +0.58% | +9.68% | +21.12% | +0.82% | -0.94% | -7.96% | +24.88% | +92.15% | 246B | |
| +0.45% | +5.02% | +2.39% | -7.16% | -48.55% | -59.36% | -30.31% | +50.70% | +69.88% | 223B | |
| +0.11% | -3.68% | -5.51% | +14.96% | +21.91% | +15.94% | +14.80% | +38.47% | +100.96% | 171B | |
| -2.28% | -0.68% | -2.43% | +5.11% | +30.35% | +30.33% | +35.98% | +101.20% | +19.81% | 153B | |
| +0.19% | -0.69% | -0.08% | +8.29% | -2.56% | +1.89% | -50.44% | -34.07% | -19.67% | 147B | |
| -0.38% | -1.48% | -6.43% | +3.20% | -11.12% | -8.73% | -6.10% | +6.11% | +9.03% | 120B | |
| +1.37% | -0.76% | +4.11% | +14.58% | +12.25% | -2.60% | +43.87% | +98.15% | +290.70% | 113B | |
| +2.36% | +0.50% | +6.78% | +13.44% | -7.34% | -6.88% | -33.57% | -12.61% | -23.65% | 104B | |
| +0.19% | -0.08% | 0.00% | +20.23% | +35.50% | +36.11% | +25.15% | +3.28% | +12.49% | 98.11B | |
| +1.99% | +0.84% | +13.59% | +28.54% | +22.06% | +26.81% | +135.15% | +69.13% | +503.04% | 88.78B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -0.19% | +3.31% | +3.64% | -7.34% | +37.86% | +31.42% | +63.01% | -15.16% | +312.45% | 59.66B | |
| -3.65% | -13.22% | -12.19% | -14.67% | +68.95% | +62.09% | +68.55% | +199.61% | +350.07% | 54.51B | |
| -0.51% | -0.56% | +5.28% | -1.24% | +6.39% | +8.01% | +8.73% | +14.94% | -23.69% | 45.49B | |
| Average | +0.03% | -0.72% | +1.86% | +10.02% | +18.05% | +16.34% | +28.77% | +71.02% | +182.76% | 218.69B | |
| Weighted average by Cap. | +0.39% | -0.03% | +2.39% | +15.87% | +21.58% | +20.20% | +49.55% | +151.60% | +330.10% |
- Stock Market
- Equities
- ROG Stock
- Sector Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition